NeuroLife

Columbus, United States

NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.

$2.9M raised

Jun 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NeuroLife raised?

NeuroLife has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in June 2026.

Who are NeuroLife's investors?

NeuroLife's investors include The NeuroTech Institute, Battelle.

Where is NeuroLife headquartered?

NeuroLife is headquartered in Columbus, United States.

What does NeuroLife do?

NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.

What stage is NeuroLife at?

NeuroLife is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 25, 2026.

MLA

"NeuroLife — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/neurolife. Accessed July 3, 2026.

APA

VCBacked. (2026). NeuroLife — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/neurolife

Wikipedia (cite web)

{{cite web |title=NeuroLife — Funding & Investors |url=https://www.vcbacked.co/company/neurolife |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 25, 2026.